Clarinase

Medicinal product

(Invented) name

Clarinase

Active substance (s)

Loratadinas/Pseudoefedrino sulfatas

Strength

10 mg/240 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AX13, Loratadine

R01BA52, Pseudoephedrine, combinations

Marketing authorisation holder

UAB Bayer, Lietuva

Date of authorisation

1998-11-27

Date of renewal

2009-10-14

Documents

1717 Pakuotės lapelis 2020_07_15.docx

1717 Clarinase pailg atpal tab II PL 2020_07_15.docx

Stage

Išregistruotas

Controlled?

Yes

Controlled substance type

Psichotropinis

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Loratadinas	10 mg
Pseudoefedrino sulfatas	240 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
9198	13865	1013865	lizdinė plokštelė	N7		Receptinis	LT/1/98/1717/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2023-06-29	Išregistruotas
2009-10-14	Perregistruotas
1998-11-27	Registruotas